Thermo Fisher Scientific Inc (TMO) financial statements (2021 and earlier)

Company profile

Business Address 168 THIRD AVENUE
WALTHAM, MA 02451
State of Incorp. DE
Fiscal Year End December 31
SIC 3829 - Measuring and Controlling Devices, Not Elsewhere Classified (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments10,3257,5405,8182,9812,3991,2732,288
Cash and cash equivalents10,3257,5405,8182,9812,3991,2732,288
Receivables5,7415,1864,4784,5084,3494,3844,129
Inventory, net of allowances, customer advances and progress billings4,0293,8293,6483,4543,3703,3083,209
Inventory4,0293,8293,6483,4543,3703,3083,209
Contract with customer, asset731697686658603  
Other current assets1,1319821,1451,1371,1721,5491,597
Total current assets:21,95718,23415,77512,73811,89310,51411,223
Noncurrent Assets
Property, plant and equipment5,9125,1804,8874,7364,7494,4204,394
Intangible assets, net (including goodwill)38,72638,65238,87039,15739,72839,93540,620
Goodwill26,04125,78225,70025,61425,71425,62425,757
Intangible assets, net (excluding goodwill)12,68512,87013,17013,54314,01414,31114,863
Other noncurrent assets2,4571,9952,0612,0572,0111,8601,733
Total noncurrent assets:47,09545,82745,81845,95046,48846,21546,747
TOTAL ASSETS:69,05264,06161,59358,68858,38156,72957,970
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities4,0913,2412,5692,3542,9302,5422,200
Accounts payable2,1751,7031,3851,5991,9201,6591,391
Employee-related liabilities1,9161,5381,1847551,010883809
Deferred revenue1,2711,047975938916943 
Debt2,62826757386766612,377
Contract with customer, liability1,062
Other liabilities2,3141,9381,7941,4701,6751,6981,870
Total current liabilities:10,3046,2286,0135,5006,1975,8447,509
Noncurrent Liabilities
Long-term debt and lease obligation, including:19,10721,09120,63819,23117,07616,39216,663
Long-term debt, excluding current maturities19,10721,09120,63819,23117,07616,392 
Other undisclosed long-term debt and lease obligation      16,663
Liabilities, other than long-term debt5,1344,9185,0675,3985,4335,1383,665
Contract with customer, liability532
Deferred income tax liabilities1,7941,5281,7502,1372,1922,001 
Other liabilities3,3403,3903,3173,2613,2413,1373,133
Total noncurrent liabilities:24,24126,00925,70524,62922,50921,53020,328
Total liabilities:34,54532,23731,71830,12928,70627,37427,837
Stockholders' equity
Stockholders' equity attributable to parent34,50731,82429,87528,55929,67529,35528,729
Common stock437437436435434434433
Treasury stock, value(6,818)(6,815)(6,766)(6,765)(5,236)(4,486)(4,443)
Additional paid in capital15,57915,46715,33415,18615,06414,96414,887
Accumulated other comprehensive loss(2,807)(2,970)(2,989)(3,088)(2,679)(2,722)(2,630)
Retained earnings28,11625,70523,86022,79122,09221,16520,482
Total stockholders' equity:34,50731,82429,87528,55929,67529,35528,729
Other undisclosed liabilities and equity      1,404
TOTAL LIABILITIES AND EQUITY:69,05264,06161,59358,68858,38156,72957,970

Income statement (P&L) ($ in millions)

12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
Revenues10,5508,5216,9176,2306,8296,2726,316
Cost of revenue(4,583)(4,207)(3,552)(3,063)(3,352)(3,540)(3,009)
Gross profit:5,9674,3143,3653,1673,4772,7323,307
Operating expenses(2,896)(1,888)(1,974)(2,261)(2,245)(1,786)(1,811)
Operating income:3,0712,4261,3919061,2329461,496
Nonoperating income (expense)(33)(30)(1)48(52)4078
Investment income, nonoperating129836455260
Other nonoperating income (expense)(45)(39)(9)12(97)(12)18
Interest and debt expense(146)(144)(137)(126)(142)(164)(181)
Income from continuing operations before income taxes:2,8922,2521,2538281,0388221,393
Income tax expense(394)(319)(97)(40)(36)(62)(274)
Net income available to common stockholders, diluted:2,4981,9331,1567881,0027601,119

Comprehensive Income ($ in millions)

12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
Net income:2,4981,9331,1567881,0027601,119
Other comprehensive income (loss)(1) 4(6)29(2)3
Comprehensive income:2,4971,9331,1607821,0317581,122
Other undisclosed comprehensive income (loss), net of tax, attributable to parent1641995(403)14(90)(124)
Comprehensive income, net of tax, attributable to parent:2,6611,9521,2553791,045668998

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: